Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications

Conditions

• Influenza

Interventions

• COMBINATION_PRODUCT: CD388 Injection
• COMBINATION_PRODUCT: Placebo

Sponsor

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)